1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. KEY FINDINGS
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. NANOTECHNOLOGY IN HEALTHCARE MARKET BY COMPONENTS
5.1. Nanomedicine
5.2. Nanomedical devices
6. NANOTECHNOLOGY IN HEALTHCARE MARKET BY TYPE
6.1. Drug delivery
6.2. Nanoscale therapeutics
6.3. Biosensors
6.4. Implantable devices
6.5. Imaging devices
6.6. Others
7. NANOTECHNOLOGY IN HEALTHCARE MARKET BY APPLICATION
7.1. Oncology
7.2. Cardiovascular
7.3. Neurology
7.4. Anti-infectory
7.5. Anti-inflammatory
7.6. Others
8. NANOTECHNOLOGY IN HEALTHCARE MARKET BY GEOGRAPHY
8.1. North America
8.1.1. USA
8.1.2. Canada
8.1.3. Others
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. Germany
8.3.2. United Kingdom
8.3.3. France
8.3.4. Others
8.4. Middle East and Africa
8.4.1. Saudi Arabia
8.4.2. Israel
8.4.3. UAE
8.4.4. Others
8.5. Asia Pacific
8.5.1. Japan
8.5.2. South Korea
8.5.3. China
8.5.4. India
8.5.5. Others
9. COMPETITIVE INTELLIGENCE
9.1. Competitive Benchmarking and Analysis
9.2. Recent Investments and Deals
9.3. Strategies of Key Players
10. COMPANY PROFILES
10.1. Lauren Sciences LLC
10.2. Nanobiotics SA
10.3. Novartis AG
10.4. Gilead Sciences Inc
10.5. Amgen Inc
10.6. Pfizer Inc
10.7. Hoffman-La Roche Ltd
10.8. UCB SA
10.9. Sanofi
LIST OF FIGURES
LIST OF TABLES